Revamped has the potential to reduce the intensity of NSAID-induced small intestinal injury: A double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Phase of Trial: Phase I/II
Latest Information Update: 01 Jan 2011
At a glance
- Drugs Rebamipide (Primary) ; Diclofenac; Omeprazole
- Indications NSAID-induced gastrointestinal damage; Pain
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.